<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02456909</url>
  </required_header>
  <id_info>
    <org_study_id>NICU_RCT</org_study_id>
    <nct_id>NCT02456909</nct_id>
  </id_info>
  <brief_title>Patient Controlled Analgesia Pump Cues on Patient Satisfaction</brief_title>
  <acronym>PCA Cues</acronym>
  <official_title>The Effect of Patient Controlled Analgesia Pump Cues on Patient Satisfaction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical College of Wisconsin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Children's Hospital and Health System Foundation, Wisconsin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical College of Wisconsin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To examine whether providing patients with a cue to the availability of pain medication&#xD;
      affects patient satisfaction, patient anxiety, PCA efficacy, and safety.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Post-operative pain is primarily managed via Patient-Controlled Analgesia (PCA). The newest&#xD;
      PCA pumps can be programmed so that the button is backlit with a green light at the end of&#xD;
      the lockout period, and the green light flashes when the medication is being dispensed. No&#xD;
      studies have examined whether this type of visual cue would influence satisfaction or other&#xD;
      patient outcomes (such as opioid consumption, PCA safety and patient anxiety) in children and&#xD;
      adolescents, and no studies have examined whether pediatric patients' perspectives would be&#xD;
      similar to those of adults.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Actual">October 3, 2019</completion_date>
  <primary_completion_date type="Actual">October 3, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient Satisfaction Questionnaire</measure>
    <time_frame>Up to 72 hours</time_frame>
    <description>Patient satisfaction with their PCA pump. Satisfaction was measured on a 0 to 10 scale, with higher numbers indicating greater satisfaction.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opioid Consumption (Total Amount of Opioid Consumed Post-operatively)</measure>
    <time_frame>Post-op Days [POD] 0 - 2, up to 72 hours</time_frame>
    <description>Total amount of opioid consumed post-operatively in mg/kg/hour.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety (State Anxiety on POD 1 and POD 2)</measure>
    <time_frame>Up to 72 hours</time_frame>
    <description>State anxiety on POD 1 and POD 2. The total score is presented as a T-score, which ranges from 0 to 100, with higher scores indicating greater levels of state anxiety. With a T-score, the mean is always 50, and the standard deviation is always 10.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">176</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Cues</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The PCA pump will be programmed to provide a cue to the end of the lockout period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Cues</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The PCA pump will be programmed such that no cues will be provided to the end of the lockout period (current standard of care).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Patient-Controlled Analgesia pump with Cues</intervention_name>
    <description>The end of the lockout period will be cued via the PCA pump</description>
    <arm_group_label>Cues</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Patient-Controlled Analgesia pump without Cues</intervention_name>
    <description>The PCA pump will be programmed such that no cues will be provided to the end of the lockout period.</description>
    <arm_group_label>No Cues</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>Morphine will be administered for post-operative pain in both the Cues and Non-Cues groups</description>
    <arm_group_label>Cues</arm_group_label>
    <arm_group_label>No Cues</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  7-18 years&#xD;
&#xD;
          -  Opioid na√Øve&#xD;
&#xD;
          -  Scheduled for a surgery for which a PCA is routinely used for post-operative pain&#xD;
             management&#xD;
&#xD;
          -  At least 1 parent speaks English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prior experience with PCA&#xD;
&#xD;
          -  Cognitive delay precluding independent use of the PCA button&#xD;
&#xD;
          -  Current use of anxiolytics or antidepressants&#xD;
&#xD;
          -  Patients receiving epidural analgesia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Keri R. Hainsworth, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical College of Wisconsin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>April 27, 2015</study_first_submitted>
  <study_first_submitted_qc>May 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 29, 2015</study_first_posted>
  <results_first_submitted>June 11, 2021</results_first_submitted>
  <results_first_submitted_qc>August 11, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">September 8, 2021</results_first_posted>
  <last_update_submitted>August 11, 2021</last_update_submitted>
  <last_update_submitted_qc>August 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical College of Wisconsin</investigator_affiliation>
    <investigator_full_name>Keri Hainsworth</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 30, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/09/NCT02456909/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants could not be recruited after surgery; therefore, all eligible participants were recruited, but not all received a PCA after surgery.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Cues</title>
          <description>The PCA pump will be programmed to provide a cue to the end of the lockout period.&#xD;
Patient-Controlled Analgesia pump with Cues: The end of the lockout period will be cued via the PCA pump&#xD;
Morphine: Morphine will be administered for post-operative pain in both the Cues and Non-Cues groups</description>
        </group>
        <group group_id="P2">
          <title>No Cues</title>
          <description>The PCA pump will be programmed such that no cues will be provided to the end of the lockout period (current standard of care).&#xD;
Patient-Controlled Analgesia pump without Cues: The PCA pump will be programmed such that no cues will be provided to the end of the lockout period.&#xD;
Morphine: Morphine will be administered for post-operative pain in both the Cues and Non-Cues groups</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="88"/>
                <participants group_id="P2" count="88"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="64"/>
                <participants group_id="P2" count="61"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Did not receive allocated intervention</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Did not complete the primary outcome</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Cues</title>
          <description>The PCA pump will be programmed to provide a cue to the end of the lockout period.&#xD;
Patient-Controlled Analgesia pump with Cues: The end of the lockout period will be cued via the PCA pump&#xD;
Morphine: Morphine will be administered for post-operative pain in both the Cues and Non-Cues groups</description>
        </group>
        <group group_id="B2">
          <title>No Cues</title>
          <description>The PCA pump will be programmed such that no cues will be provided to the end of the lockout period (current standard of care).&#xD;
Patient-Controlled Analgesia pump without Cues: The PCA pump will be programmed such that no cues will be provided to the end of the lockout period.&#xD;
Morphine: Morphine will be administered for post-operative pain in both the Cues and Non-Cues groups</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="64"/>
            <count group_id="B2" value="61"/>
            <count group_id="B3" value="125"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                    <measurement group_id="B2" value="61"/>
                    <measurement group_id="B3" value="125"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                    <measurement group_id="B2" value="61"/>
                    <measurement group_id="B3" value="125"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11" lower_limit="9.0" upper_limit="11.5"/>
                    <measurement group_id="B2" value="11" lower_limit="9.0" upper_limit="12.0"/>
                    <measurement group_id="B3" value="11" lower_limit="9.0" upper_limit="12.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="77"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="58"/>
                    <measurement group_id="B2" value="52"/>
                    <measurement group_id="B3" value="110"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="95"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Patient Satisfaction Questionnaire</title>
        <description>Patient satisfaction with their PCA pump. Satisfaction was measured on a 0 to 10 scale, with higher numbers indicating greater satisfaction.</description>
        <time_frame>Up to 72 hours</time_frame>
        <population>Includes participants who completed the post-intervention survey.</population>
        <group_list>
          <group group_id="O1">
            <title>Cues</title>
            <description>The PCA pump will be programmed to provide a cue to the end of the lockout period.&#xD;
Patient-Controlled Analgesia pump with Cues: The end of the lockout period will be cued via the PCA pump&#xD;
Morphine: Morphine will be administered for post-operative pain in both the Cues and Non-Cues groups</description>
          </group>
          <group group_id="O2">
            <title>No Cues</title>
            <description>The PCA pump will be programmed such that no cues will be provided to the end of the lockout period (current standard of care).&#xD;
Patient-Controlled Analgesia pump without Cues: The PCA pump will be programmed such that no cues will be provided to the end of the lockout period.&#xD;
Morphine: Morphine will be administered for post-operative pain in both the Cues and Non-Cues groups</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Satisfaction Questionnaire</title>
          <description>Patient satisfaction with their PCA pump. Satisfaction was measured on a 0 to 10 scale, with higher numbers indicating greater satisfaction.</description>
          <population>Includes participants who completed the post-intervention survey.</population>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" lower_limit="6" upper_limit="9"/>
                    <measurement group_id="O2" value="7.5" lower_limit="5" upper_limit="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Opioid Consumption (Total Amount of Opioid Consumed Post-operatively)</title>
        <description>Total amount of opioid consumed post-operatively in mg/kg/hour.</description>
        <time_frame>Post-op Days [POD] 0 - 2, up to 72 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cues</title>
            <description>The PCA pump will be programmed to provide a cue to the end of the lockout period.&#xD;
Patient-Controlled Analgesia pump with Cues: The end of the lockout period will be cued via the PCA pump&#xD;
Morphine: Morphine will be administered for post-operative pain in both the Cues and Non-Cues groups</description>
          </group>
          <group group_id="O2">
            <title>No Cues</title>
            <description>The PCA pump will be programmed such that no cues will be provided to the end of the lockout period (current standard of care).&#xD;
Patient-Controlled Analgesia pump without Cues: The PCA pump will be programmed such that no cues will be provided to the end of the lockout period.&#xD;
Morphine: Morphine will be administered for post-operative pain in both the Cues and Non-Cues groups</description>
          </group>
        </group_list>
        <measure>
          <title>Opioid Consumption (Total Amount of Opioid Consumed Post-operatively)</title>
          <description>Total amount of opioid consumed post-operatively in mg/kg/hour.</description>
          <units>mg/kg/hr</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
                <count group_id="O2" value="61"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Post-op Day 0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0252" lower_limit="0.015" upper_limit="0.038"/>
                    <measurement group_id="O2" value="0.0248" lower_limit="0.015" upper_limit="0.034"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-op Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0214" lower_limit="0.012" upper_limit="0.031"/>
                    <measurement group_id="O2" value="0.0163" lower_limit="0.011" upper_limit="0.028"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-op Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0162" lower_limit="0.0045" upper_limit="0.024"/>
                    <measurement group_id="O2" value="0.0125" lower_limit="0.0057" upper_limit="0.023"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Anxiety (State Anxiety on POD 1 and POD 2)</title>
        <description>State anxiety on POD 1 and POD 2. The total score is presented as a T-score, which ranges from 0 to 100, with higher scores indicating greater levels of state anxiety. With a T-score, the mean is always 50, and the standard deviation is always 10.</description>
        <time_frame>Up to 72 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cues</title>
            <description>The PCA pump will be programmed to provide a cue to the end of the lockout period.&#xD;
Patient-Controlled Analgesia pump with Cues: The end of the lockout period will be cued via the PCA pump&#xD;
Morphine: Morphine will be administered for post-operative pain in both the Cues and Non-Cues groups</description>
          </group>
          <group group_id="O2">
            <title>No Cues</title>
            <description>The PCA pump will be programmed such that no cues will be provided to the end of the lockout period (current standard of care).&#xD;
Patient-Controlled Analgesia pump without Cues: The PCA pump will be programmed such that no cues will be provided to the end of the lockout period.&#xD;
Morphine: Morphine will be administered for post-operative pain in both the Cues and Non-Cues groups</description>
          </group>
        </group_list>
        <measure>
          <title>Anxiety (State Anxiety on POD 1 and POD 2)</title>
          <description>State anxiety on POD 1 and POD 2. The total score is presented as a T-score, which ranges from 0 to 100, with higher scores indicating greater levels of state anxiety. With a T-score, the mean is always 50, and the standard deviation is always 10.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
                <count group_id="O2" value="61"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>POD 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55" lower_limit="48.00" upper_limit="62.00"/>
                    <measurement group_id="O2" value="55" lower_limit="49.00" upper_limit="60.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>POD 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.5" lower_limit="46.00" upper_limit="61.00"/>
                    <measurement group_id="O2" value="52" lower_limit="46.00" upper_limit="58.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>72 hours</time_frame>
      <desc>Deaths were not assessed in this protocol.</desc>
      <group_list>
        <group group_id="E1">
          <title>Cues</title>
          <description>The PCA pump will be programmed to provide a cue to the end of the lockout period.&#xD;
Patient-Controlled Analgesia pump with Cues: The end of the lockout period will be cued via the PCA pump&#xD;
Morphine: Morphine will be administered for post-operative pain in both the Cues and Non-Cues groups</description>
        </group>
        <group group_id="E2">
          <title>No Cues</title>
          <description>The PCA pump will be programmed such that no cues will be provided to the end of the lockout period (current standard of care).&#xD;
Patient-Controlled Analgesia pump without Cues: The PCA pump will be programmed such that no cues will be provided to the end of the lockout period.&#xD;
Morphine: Morphine will be administered for post-operative pain in both the Cues and Non-Cues groups</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="64"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Itching requiring treatment on POD 0</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="64"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Keri R. Hainsworth, PhD</name_or_title>
      <organization>Medical College of Wisconsin</organization>
      <phone>414-266-6306</phone>
      <email>khainswo@mcw.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

